Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Methyl Aminolevulinate
Therapeutic Area : Dermatology
Study Phase : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
PRO With Luxerm® in the Field Treatment of Thin and Non-hyperkeratotic Non-pigmented AK
Details : Undisclosed
Product Name : Undisclosed
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
April 27, 2018
Lead Product(s) : Methyl Aminolevulinate
Therapeutic Area : Dermatology
Highest Development Status : Phase IV
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Methyl Aminolevulinate
Therapeutic Area : Dermatology
Study Phase : Phase III
Sponsor : Galderma
Deal Size : Inapplicable
Deal Type : Inapplicable
Actinic Keratoses Treatment With Metvix® in Combination With Light
Details : Undisclosed
Product Name : Metvix
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
February 27, 2015
Lead Product(s) : Methyl Aminolevulinate
Therapeutic Area : Dermatology
Highest Development Status : Phase III
Sponsor : Galderma
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Methyl Aminolevulinate
Therapeutic Area : Dermatology
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Undisclosed
Product Name : Metvix
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
November 21, 2011
Lead Product(s) : Methyl Aminolevulinate
Therapeutic Area : Dermatology
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable